Botulinum toxin in masticatory muscles: Short- and long-term effects on muscle, bone, and craniofacial function in adult rabbits

Bone

Volumn 50, Issue 3, 2012, Pages 651-662

  Rafferty, Katherine L ^a   Liu, Zi Jun ^a   Ye, Wenmin ^a   Navarrete, Alfonso L ^a   Nguyen, Thao Tuong ^a   Salamati, Atriya ^a   Herring, Susan W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bone microarchitecture; Botulinum neurotoxin; Mandibular bone strain; Masseter; Temporomandibular joint

Indexed keywords

BOTULINUM TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAM; EXPERIMENTAL RABBIT; FEMALE; MANDIBLE CONDYLE; MASSETER MUSCLE; MASTICATION; MASTICATORY MUSCLE; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE MASS; NONHUMAN; OSTEOLYSIS; PARALYSIS; STIMULUS RESPONSE; TEMPOROMANDIBULAR JOINT;

ANIMALS; BITE FORCE; BONE AND BONES; BOTULINUM TOXINS; FEMALE; MANDIBULAR CONDYLE; MASSETER MUSCLE; MASTICATION; RABBITS;

EID: 84856948517     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.11.015     Document Type: Article

References (53)

1. Fehlings D., Novak I., Berweck S., Hoare B., Stott N.S., Russo R.N. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol 2010, 17(Suppl. 2):38-56.
2. Friedman B.C., Goldman R.D. Use of botulinum toxin A in management of children with cerebral palsy. Can Fam Physician 2011, 57:1006-1073.
3. Intiso D. Therapeutic use of botulinum toxin in neurorehabilitation. J Toxicol 2012, 2012: 802893, PMC3172973.
4. Kim N.H., Chung J.H., Park R.H., Park J.B. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005, 115:919-930.
5. Kim N.H., Park R.H., Park J.B. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle. Plast Reconstr Surg 2010, 125:1693-1705.
6. Al-Muharraqi M.A., Fedorowicz Z., Bareeq A., Al Bareeq R., Nasser M. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev 2009, 21. art. no. CD007510.
7. Schwartz M., Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 2002, 18:S198-S203.
8. Canter H.I., Kayikcioglu A., Aksu M., Mavili M.E. Botulinum toxin in closed treatment of mandibular condylar fracture. Ann Plast Surg 2007, 58:474-478.
9. Ihde S.K.A., Konstantinovic V.S. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:e1-e11.
10. Clark G.T., Stiles A., Lockerman L.Z., Gross S.G. A critical review of the use of botulinum toxin in orofacial pain disorders. Dent Clin North Am 2007, 51:245-261.
11. Kim C., McCall W.D., Kim Y.K., Chung J.W. Effect of botulinum toxin on pressure pain threshold and EMG power spectrum of masseter muscle during sustained fatiguing contraction. Am J Phys Med Rehabil 2010, 89:736-743.
12. Ernberg M., Hedenberg-Magnusson B., List T., Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 2011, epub ahead of print.
13. Poliachik S.L., Bain S.D., Threet D., Huber P., Gross T.S. Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone 2010, 46:18-23.
14. Warner S.E., Sanford D.A., Becker B.A., Bain S.D., Srinivasan S., Gross T.S. Botox induced muscle paralysis rapidly degrades bone. Bone 2006, 38:257-264.
15. Manske S.L., Boyd S.K., Zernicke R.F. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection. Bone 2010, 46:24-31.
16. Manske S.L., Boyd S.K., Zernicke R.F. Vertical ground reaction forces diminish in mice after botulinum toxin injection. J Biomech 2011, 44:637-643.
17. Rawlinson S.C.F., Mosley J.R., Suswillo R.F.L., Pitsillides A.A., Lanyon L.E. Calvarial and limb bone cells in organ and monolayer culture do not show the same early responses to dynamic mechanical strain. J Bone Miner Res 1995, 10:1225-1232.
18. Mavropoulos A., Odman A., Ammann P., Kiliaridis S. Rehabilitation of masticatory function improves the alveolar bone architecture of the mandible in adult rats. Bone 2010, 47:687-692.
19. Matic D.B., Yazdani A., Wells R.G., Lee T.Y., Gan B.S. The effects of masseter muscle paralysis on facial bone growth. J Surg Res 2007, 139:243-252.
20. Tsai C.-Y., Shyr Y.-M., Chiu W.-C., Lee C.-M. Bone changes in the mandible following botulinum neurotoxin injections. Eur J Orthod 2011, 33:132-138.
21. Tsai C.-Y., Huang R.-Y., Lee C.-M., Hsiao W.-T., Yang L.-Y. Morphologic and bony structural changes in the mandible after a unilateral injection of botulinum neurotoxin in adult rats. J Oral Maxillofac Surg 2010, 68:1081-1087.
22. Tsai C.Y., Yang L.Y., Chen K.T., Chiu W.C. The influence of masticatory hypofunction on developing rat craniofacial structure. Int J Oral Maxillofac Surg 2010, 39:593-598.
23. Tsai C.-Y., Chiu W.C., Liao Y.-H., Tsai C.M. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscles. Am J Orthod Dentofacial Orthop 2009, 135. 142.e1-142.e6.
24. Gross T.S., Poliachik S.L., Prasad J., Bain S.D. The effect of muscle dysfunction on bone mass and morphology. J Musculoskelet Neuronal Interact 2010, 10:25-34.
25. Manske S.L., Boyd S.K., Zernicke R.F. Muscle changes can account for bone loss after botulinum toxin injection. Calcif Tissue Int 2010, 87:541-549.
26. Ahn K.Y., Kim S.T. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plast Reconstr Surg 2007, 120:1662-1666.
27. Yu C.-C., Chen P.K.-T., Chen Y.-R. Botulinum toxin A for lower facial contouring: a prospective study. Aesthetic Plast Surg 2007, 31:445-451.
28. Lee C.J., Kim S.G., Kim Y.J., Han J.Y., Choi S.H., Lee S.I. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast Reconstr Surg 2007, 120:769-778.
29. Freund B., Schwartz M. The use of botulinum toxin for the treatment of temporomandibular disorder. Oral Health 1998, 88:32-37.
30. Freund B., Schwartz M., Symington J.M. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 1999, 57:916-920. discussion 920-1.
31. Weijs W.A., Dantuma R. Functional anatomy of the masticatory apparatus in the rabbit (Oryctolagus cuniculus L.). Netherl J Zool 1981, 31:99-147.
32. de Jong W.C., Koolstra J.H., Korfage J.A.M., van Ruijven L.J., Langenbach G.E.J. The daily habitual in vivo strain history of a non-weight-bearing bone. Bone 2010, 46:196-202.
33. van Wessel T., Langenbach G.E.J., Kawai N., Brugman P., Tanaka E., Van Eijden T.M.G.J. Burst characteristics of daily jaw muscle activity in juvenile rabbits. J Exp Biol 2005, 208:2539-2547.
34. Bredman J.J., Weijs W.A., Korfage H.A., Brugman P., Moorman A.F. Myosin heavy chain expression in rabbit masseter muscle during postnatal development. J Anat 1992, 180:263-274.
35. Widmer C.G., Klugman D., English A.W. Anatomical partitioning and nerve branching patterns in the adult rabbit masseter. Acta Anat 1997, 159:222-232.
36. Dechow P.C., Carlson D.S. A method of bite force measurements in primates. J Biomech 1983, 16:797-802.
37. Weijs W.A., Hillen B. Relationship between the physiological cross-section of the human jaw muscles and their cross-sectional area in computer tomograms. Acta Anat 1984, 118:129-138.
38. Parsa A.A., Lye K.D., Parsa F.D. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use. Aesthetic Plast Surg 2007, 31:188-191. discussion 192-3.
39. Micro-Measurements Strain gage rosettes: selection, application and data reduction. Vishay Precision Group Tech Note TN-515 2010, 151-162.
40. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
41. Snedecor G.W., Cochran W.G. Statistical methods 1967, Iowa State Univ. Press, Ames, Iowa. 6th ed.
42. Yaraskavitch M., Leonard T., Herzog W. Botox produces functional weakness in non-injected muscles adjacent to the target muscle. J Biomech 2008, 41:897-902.
43. Tan E.K., Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 1999, 53:2102-2107.
44. Fortuna R., Vaz M.A., Rehan Youssef A., Longino D., Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin. J Biomech 2011, 44:39-44.
45. Allergan Inc. Package insert for Botox Cosmetic 2002.
46. Kim J.H., Shin J.H., Kim S.T., Kim C.Y. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 2007, 119:711-717.
47. Kim K.S., Byun Y.S., Kim Y.J., Kim S.T. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle. Dermatol Surg 2009, 35:1902-1907.
48. Weijs W.A., de Jongh H.J. Strain in mandibular alveolar bone during mastication in the rabbit. Arch Oral Biol 1977, 22:667-675.
49. Da Ré Guerra F., de Souza Pires I.L., de Aro A.A., Camargo L.C., Pimentel E.R., Palomari E.T. Protocol on induction of TMJ articular disc degeneration in rats by utilization of botulinum toxin. Arch Oral Biol 2010, 55:530-534.
50. Luder H.-U. Postnatal development, aging, and degeneration of the temporomandibular joint in humans, monkeys, and rats 1996, Center for Human Growth and Development, Univ. of Michigan, Ann Arbor, MI.
51. Zhao C., Kurita H., Kurashina K., Hosoya A., Arai Y., Nakamura H. Temporomandibular joint response to mandibular deviation in rabbits detected by 3D micro-CT imaging. Arch Oral Biol 2010, 55:929-937.
52. To E.W., Ahuja A.T., Ho W.S., King W.W., Wong W.K., Pang P.C., et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001, 54:197-200.
53. Dodd S.L., Selsby J., Payne A., Judge A., Dott C. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle. Toxicon 2005, 46:196-203.